

ACCESS BIO
Access to
Life, Bio for
Hope
Access Bio is dedicated to developing innovations for early diagnosis and prevention of infectious diseases – and making sure our products are available where they can do the most good.


CARESTART™
COVID-19
MDx RT-PCR
For the qualitative detection of human coronavirus SARS-CoV-2 viral RNA extracted from nasopharyngeal and oropharyngeal swab specimens.
Learn more


CARESTART™
COVID-19
IgM/IgG
Rapid diagnostic test for the detection of human coronavirus SARS-CoV-2 lgM/lgG antibody.
Learn more
About Us
A Trusted Partner in GlobaL HEALTH
Access Bio’s mission is to improve the lives and well-being of people around the world. Through the development of in vitro diagnostics technology, Access Bio has successfully commercialized the highest quality products to battle malaria and other serious diseases.
We are a trusted partner to international public health agencies and organizations, including the World Health Organization, the Bill and Melinda Gates Foundation, UNICEF, and many others.
product infoRMATION
We are here
to answer any questions you may have
Join The Access Bio Health Movement.
The Mission
The True Value
of INNOVATION
We strive to bring additional value to our business partners by meeting the market demands for accurate and cost-effective in vitro diagnosis at a whole new level of technology and product development.

The Range
Leading the fight
against COVID-19
A challenge as complex as the Covid-19 pandemic requires innovative, adaptable solutions. To meet the need for accurate, reliable screening, we have a suite of products that includes PCR, serology, and antigen testing.
The Range
Leading the fight against COVID-19
A challenge as complex as the Covid-19 pandemic requires innovative, adaptable solutions. To meet the need for accurate, reliable screening, we have a suite of products that includes PCR, serology, and antigen testing, and the capacity to produce up to 1.2 million tests a day.

Access Bio News
Stay Up to Date with
Access Bio News and
Events
Read about our new product releases and events, and learn more about how Access Bio products are helping to fight disease all over the world.
Learn more
PARTNERSHIPS
McKesson Medical Surgical Signs National Distribution Agreement
December 17, 2020
Learn more
PARTNERSHIPS
Concordance Healthcare Solutions and NDC Ink National Distribution Agreements
December 03, 2020
Learn more
Stay up to date
Sign up to keep being notified about the latest Access Bio news.
Access Bio News
Stay Up to Date with Access Bio News and Events
Read about our new product releases and events, and learn more about how Access Bio products are helping to fight disease all over the world.
Learn more

PARTNERSHIPS
McKesson Medical Surgical Signs National Distribution Agreement
Learn More
December 17, 2020

PARTNERSHIPS
Concordance Healthcare Solutions and NDC Ink National Distribution Agreements
Learn More
December 03, 2020




Stay up to date
Sign up to keep being notified about the latest Access Bio news.
Our Work Has Just Begun
As we look toward the future, Access Bio will not merely respond to the changing environment, but move forward with a proactive stance.
With efficient processes and a dynamic culture, we will harness our competitive advantage to develop next-generation technologies and sustain growth. As a world leader in medical diagnosis, Access Bio is committed in promoting hope for a healthy life and garnering the trust of all stakeholders.
Thank you.
Young H. Choi – Chairman & CEO


Our Work Has Just Begun
As we look toward the future, Access Bio will not merely respond to the changing environment, but move forward with a proactive stance.
With efficient processes and a dynamic culture, we will harness our competitive advantage to develop next-generation technologies and sustain growth. As a world leader in medical diagnosis, Access Bio is committed in promoting hope for a healthy life and garnering the trust of all stakeholders.
Thank you.
Young H. Choi – Chairman & CEO